Avanos Medical Inc (AVNS)

Operating return on assets (Operating ROA)

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Operating income (ttm) US$ in thousands -383,000 57,700 46,900 28,700 23,900 27,900 45,400 66,500 73,100 71,900 56,800 30,500 8,900 -60,900 -64,600 -59,100 -46,100 -4,500 -22,500 -30,500
Total assets US$ in thousands 1,154,200 1,656,200 1,657,800 1,661,300 1,692,400 1,724,900 1,666,700 1,734,900 1,786,900 1,775,200 1,752,800 1,766,500 1,594,600 1,597,900 1,683,300 1,648,800 1,672,800 1,799,100 1,755,900 1,763,700
Operating ROA -33.18% 3.48% 2.83% 1.73% 1.41% 1.62% 2.72% 3.83% 4.09% 4.05% 3.24% 1.73% 0.56% -3.81% -3.84% -3.58% -2.76% -0.25% -1.28% -1.73%

December 31, 2024 calculation

Operating ROA = Operating income (ttm) ÷ Total assets
= $-383,000K ÷ $1,154,200K
= -33.18%

Avanos Medical Inc's operating return on assets (operating ROA) has exhibited significant fluctuations over the quarters. The company experienced negative operating ROA figures in the first half of 2020, with a gradual improvement towards the end of the year. Moving into 2021, the operating ROA remained negative but started to show signs of recovery, turning positive in the last quarter of the year.

In 2022 and the first half of 2023, Avanos Medical Inc's operating ROA showed a positive trend, peaking at 4.09% in December 2022. However, the operating ROA declined in the following quarters before stabilizing around 2-3%.

A notable anomaly occurred in December 2024, where the operating ROA dropped significantly to -33.18%. This sharp decline raises concerns and requires further investigation to understand the factors contributing to such a drastic decrease in operating profitability.

Overall, despite the fluctuations, Avanos Medical Inc's operating ROA has shown a general improvement from negative figures to positive values, indicating enhanced operational efficiency and profitability over the quarters, with the exception of the sudden decline in December 2024.